We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

998:HKEXChina CITIC Bank Corporation Ltd Class H Analysis

Data as of 2026-07-16 - not real-time

HK$116.90

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Alibaba’s stock is trading just above its short‑term moving averages, with momentum indicators showing mixed signals – the RSI sits in the upper range, while the MACD histogram is positive despite a negative line, and volume has been rising. Technical pressure is building near the identified resistance zone, and the broader trend is flagged as bearish, suggesting limited upside in the immediate term. Fundamentally, revenue growth is modest and margins are thin, with operating cash flow positive but free cash flow negative, and a debt load that dwarfs equity, pointing to balance‑sheet stress. The discounted cash flow model places fair value well below the current price, reinforcing a narrative of overvaluation, yet analyst consensus remains strongly positive with a high target price outlook. Recent strategic moves, such as the announced bid for a Chinese grocery delivery platform, aim to expand the ecosystem and could unlock future growth, especially in cloud services and international commerce. However, the company operates in a sector that faces heightened regulatory scrutiny in China, adding a layer of uncertainty to its outlook.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near resistance with bearish trend
  • mixed MACD signals
  • increasing volume but limited upside

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • strategic acquisition expanding grocery delivery
  • strong analyst sentiment and high target price
  • potential upside from cloud and international commerce

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • overvaluation relative to DCF fair value
  • persistent regulatory headwinds in China
  • solid cash generation despite debt burden

Key Metrics & Analysis

Financial Health

Revenue Growth2.90%
Profit Margin10.12%
P/E Ratio18.4
ROE9.22%
ROA2.12%
Debt/Equity25.01
P/B Ratio1.8
Op. Cash FlowHK$76.2B
Free Cash FlowHK$-44074250240

Technical Analysis

TrendBearish
RSI63.5
SupportHK$88.65
ResistanceHK$119.80
MA 20HK$102.06
MA 50HK$116.21
MA 200HK$141.80
MACDBullish
VolumeIncreasing
Fear & Greed Index91.55

Valuation

Fair ValueHK$42.98
Target PriceHK$180.90
Upside/Downside54.75%
GradeOvervalued
TypeBlend

Risk Assessment

Beta0.66
Volatility53.51%
Sector RiskHigh
Reg. RiskHigh
Geo RiskHigh
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.